$2.42
00.00%
Last update: Jul 19, 4:02 PM
15 minutes delayed
Comments
Loading...
Galectin Therapeutics
GALTNASDAQ
Galectin Therapeutics (NASDAQ:GALT) Stock, Earnings Estimates, EPS, And Revenue
Galectin Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 12
EPS Estimate
$-0.160
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Galectin Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GALT | Galectin Therapeutics | -$0.15 | -$0.16 | — | — | $0.00 | — | — | — | 08/12/2024 | Get Alert |
| GALT | Galectin Therapeutics | -$0.19 | -$0.16 | -$0.19 | -18.75% | $0.00 | — | $0.00 | — | 05/15/2024 | Get Alert |
| GALT | Galectin Therapeutics | -$0.18 | -$0.16 | -$0.16 | 0.00% | $0.00 | — | $0.00 | — | 03/29/2024 | Get Alert |
| GALT | Galectin Therapeutics | -$0.14 | -$0.16 | -$0.24 | -50.00% | $0.00 | — | $0.00 | — | 11/13/2023 | Get Alert |
| GALT | Galectin Therapeutics | -$0.16 | -$0.21 | -$0.15 | 28.57% | $0.00 | — | $0.00 | — | 08/14/2023 | Get Alert |
| GALT | Galectin Therapeutics | -$0.17 | -$0.21 | -$0.19 | 9.52% | $0.00 | — | $0.00 | — | 05/15/2023 | Get Alert |
| GALT | Galectin Therapeutics | -$0.12 | -$0.17 | -$0.18 | -5.88% | $0.00 | — | $0.00 | — | 03/30/2023 | Get Alert |
| GALT | Galectin Therapeutics | -$0.14 | -$0.20 | -$0.14 | 30.00% | $0.00 | — | $0.00 | — | 11/14/2022 | Get Alert |
| GALT | Galectin Therapeutics | -$0.15 | -$0.21 | -$0.16 | 23.81% | $0.00 | — | $0.00 | — | 08/15/2022 | Get Alert |
| GALT | Galectin Therapeutics | -$0.11 | -$0.14 | -$0.17 | -21.43% | $0.00 | — | $0.00 | — | 05/16/2022 | Get Alert |
| GALT | Galectin Therapeutics | -$0.13 | -$0.19 | -$0.12 | 36.84% | $0.00 | — | $0.00 | — | 03/31/2022 | Get Alert |
| GALT | Galectin Therapeutics | -$0.10 | -$0.18 | -$0.14 | 22.22% | $0.00 | — | $0.00 | — | 11/15/2021 | Get Alert |
| GALT | Galectin Therapeutics | -$0.11 | -$0.18 | -$0.14 | 22.22% | $0.00 | — | $0.00 | — | 08/16/2021 | Get Alert |
| GALT | Galectin Therapeutics | -$0.06 | -$0.17 | -$0.11 | 35.29% | $0.00 | — | $0.00 | — | 05/17/2021 | Get Alert |
| GALT | Galectin Therapeutics | -$0.12 | -$0.17 | -$0.13 | 23.53% | $0.00 | — | $0.00 | — | 03/31/2021 | Get Alert |
| GALT | Galectin Therapeutics | -$0.05 | -$0.14 | -$0.10 | 28.57% | $0.00 | — | $0.00 | — | 11/09/2020 | Get Alert |
| GALT | Galectin Therapeutics | -$0.06 | -$0.09 | -$0.11 | -22.22% | $0.00 | — | $0.00 | — | 08/10/2020 | Get Alert |
| GALT | Galectin Therapeutics | -$0.20 | -$0.09 | -$0.06 | 33.33% | $0.00 | — | $0.00 | — | 05/11/2020 | Get Alert |
| GALT | Galectin Therapeutics | -$0.08 | — | -$0.12 | — | $0.00 | — | $0.00 | — | 03/16/2020 | Get Alert |
| GALT | Galectin Therapeutics | -$0.07 | — | -$0.05 | — | $0.00 | — | $0.00 | — | 11/12/2019 | Get Alert |
| GALT | Galectin Therapeutics | -$0.11 | — | -$0.06 | — | $0.00 | — | $0.00 | — | 08/09/2019 | Get Alert |
Galectin Therapeutics (GALT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-15 | $-0.19 | $-0.16 | -18.8 % |
| Dec 2023 | 2024-03-29 | $-0.16 | $-0.16 | 0.00 % |
| Sep 2023 | 2023-11-13 | $-0.24 | $-0.16 | -50.0 % |
| Jun 2023 | 2023-08-14 | $-0.15 | $-0.21 | 28.6 % |
Galectin Therapeutics (GALT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Galectin Therapeutics (NASDAQ:GALT) reporting earnings?
Galectin Therapeutics (GALT) is scheduled to report earnings on August 12, 2024. The last reported earnings were for reported on May 15, 2024 for Q1.
What were the latest earnings per share (EPS) for Galectin Therapeutics (NASDAQ:GALT)?
The Actual EPS was $-0.19, which missed the estimate of $-0.16.
What were Galectin Therapeutics’s (NASDAQ:GALT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.